Provention Bio Inc buy Chardan Capital
Start price
13.03.23
/
50%
€22.41
Target price
13.03.24
€23.30
Performance (%)
1.07%
End price
14.03.24
-
Summary
This prediction is currently being closed. The BUY prediction by Chardan_Capital shows slight gains of 1.07%. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Provention Bio Inc | - | - | - |
iShares Core DAX® | -1.114% | 3.430% | 25.966% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% |
Comments by Chardan_Capital for this prediction
In the thread Provention Bio Inc diskutieren
Provention Bio, Inc. (NASDAQ: PRVB) had its price target lowered by analysts at Chardan Capital from $30.00 to $25.00. They now have a "buy" rating on the stock.
Ratings data for PRVB provided by MarketBeat
In the thread Trading Provention Bio Inc
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten